GT Biopharma, Inc. (GTBP)
0.46
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
0.463
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma SG&A Expense (Quarterly) : 2.748M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.867M |
| Lyell Immunopharma, Inc. | 10.69M |
| Geron Corp. | 39.00M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Crinetics Pharmaceuticals, Inc. | 52.26M |